论文部分内容阅读
目的分析我院2009年至2011年抗肿瘤药物的用药情况，对抗肿瘤药物的运用及发展趋势进行评价，并为其研究、生产、销售及临床合理应用提供参考。方法对我院近三年来抗肿瘤药物的用药频度、用药金额和销售量等数据进行统计分析。结果抗肿瘤药物的使用量呈逐年上升趋势，注射剂使用量比其它剂型多，其中平消片、香菇多糖和氟尿嘧啶的用药频度均排在前列；此外，其他抗肿瘤药物及辅助治疗药的销售金额以及品种都是最多的。结论我院抗肿瘤药物使用类型比较稳定，一般首选价格适宜、疗效确切、长期用于临床的抗肿瘤药物，所用药物基本合理。“,” Objective: The usage of antitumor drug in our hospital from 2009 to 2011 was analysed to evaluate the application and development trend of antitumor drugs, and provide reference for anticancer drug research, production, sales and clinical rational application. Methods: The data in recently three years, such as medication frequency, amount and sales of antineoplastic drugs were col ected for statistical analysis. Results: The usage amount of antitumor drug showed an upward trend year after year, in which the usage of injection was more frequent than other dosage forms, especial y pingxiao tablets, lentinan and fluorouracil were in the front row according to the usage frequency. In addition, other antitumor drugs and adjuvant drugs regardless of sales amount or varieties are the most. Conclusion: The types of antineoplastic drugs reasonably used in our hospital are relatively stable, general y preferred affordable, effective, and in the long term used for clinical antitumor drugs.